EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis

Yanyan Jia iD, Zifeng Ye iD, Fude Yang iD, Jiabao Chai iD, Haiting Xu iD, Jingming Yang iD, Weiye Liang iD, Lili Wu iD

Therapeutic Advances in Psychopharmacology · 2025-06 · 15

DOI: 10.1177/20451253251342628 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 14.06.2025. Verfasst von Yanyan Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Huilongguan Hospital, Peking University, Beijing, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post-traumatic stress disorder (PTSD) is a prevalent mental illness with a high disability rate. The neurobiological abnormalities in PTSD suggest that drug therapy may have certain therapeutic effects. According to the recommendations of clinical guidelines for PTSD, the current clinical preference is for selective serotonin reuptake inhibitors (SSRIs) or serotonin and norepinephrine reuptake inhibitors (SNRIs). Nevertheless, the efficacy of other types of drugs remains uncertain, which impacts the selection of personalized treatment for patients.

Objectives

The aim of this meta-analysis was to assess the efficacy and acceptability of drugs with different pharmacological mechanisms in alleviating PTSD symptoms by comparing the response rates and dropout rates of different drug treatment groups in randomized clinical trials.

Design

Systematic review and meta-analysis.

Methods

We searched and analyzed 52 reports that described the efficacy and acceptability of medication for PTSD. Among these, 49 trials used the dropout rate as an acceptability indicator, and 52 trials used the response rate as an efficacy indicator.

Results

In the 49 trials with the dropout rate as the indicator, the dropout rate was 29% (95% confidence interval, 0.26–0.33; n = 3870). In the 52 trials with the response rate as the indicator, the response rate was 39% (95% confidence interval, 0.33–0.45; n = 3808). After drug treatment, the core symptoms of PTSD were significantly improved. This meta-analysis indicated that there was no significant difference between antidepressants and antipsychotics in improving clinical symptoms and acceptability. However, the antipsychotics may have a slight advantage in efficacy, albeit with a higher dropout rate.

Conclusion

Drug treatment is an effective rehabilitation method for PTSD patients, and individualized drug management should be considered.

Trial registration

This systematic evaluation scheme has been registered with PROSPERO (protocol ID: CRD42023462662).

Schlagwörter

Stichwörter der Autor:innen

medicationpharmacotherapypost-traumatic stress disorder (PTSD)randomized controlled trial (RCT)treatment

Autor:innen und Institutionen

  • Beijing Huilongguan Hospital, Peking University, Beijing, China.
  • Department of Medical Psychology of Hainan Hospital, Chinese PLA General Hospital, Sanya, China.
  • Beijing Huilongguan Hospital, Peking University, No. 7 Courtyard, Nandian North Road, Changping District, Beijing 100096, China.
  • Faculty of Psychology and Mental Health, Naval Medical University, 800 Xiangyin Road, Shanghai 200433, China.

ORCID-Profile: Yanyan Jia, Zifeng Ye, Fude Yang, Jiabao Chai, Haiting Xu, Jingming Yang, Weiye Liang, Lili Wu

Förderung

  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park

Zitieren

APA

Jia, Y., Ye, Z., Yang, F., Chai, J., Xu, H., Yang, J., Liang, W., & Wu, L. (2025). Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology, 15. https://doi.org/10.1177/20451253251342628

Vancouver

Jia Y, Ye Z, Yang F, Chai J, Xu H, Yang J, et al. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis. Therapeutic Advances in Psychopharmacology. 2025;15. doi:10.1177/20451253251342628

BibTeX
@article{Jia2025,
  author = {Jia, Yanyan and Ye, Zifeng and Yang, Fude and Chai, Jiabao and Xu, Haiting and Yang, Jingming and Liang, Weiye and Wu, Lili},
  title = {Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis},
  journal = {Therapeutic Advances in Psychopharmacology},
  year = {2025},
  volume = {15},
  doi = {10.1177/20451253251342628}
}
Kostenlos starten →